Sjogren Syndrome clinical trials
28 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
- Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
- Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Open Label Treprostinil Raynaud's Study
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- The Pathogenesis and Natural History of Sjogren's Disease
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
- Deciphering the Genetic Architecture of Autoimmune Diseases
- Rheumatology Diet Study
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Rheumatology Patient Registry and Biorepository
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Characterization of Diseases With Salivary Gland Involvement
- Creating Health Course Study for People With Rheumatological Conditions
- Sjogren's Mini-Pill Oral and Gut Microbiome Study
- Penn SICCA Follow-up Study
- Comparative Autoantibody and Immunologic Cell Marker Study
- Quest to Analyze One Thousand Humans Meditating
- Patient-Centered Assessment of Symptoms and Outcomes
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Sjogren Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.